✦ LIBER ✦

Significantly Better Glycemic Control and Weight Reduction with Liraglutide, a Once-daily Human GLP-1 Analog, Compared with Insulin Glargine: All as Add-on to Metformin and a Sulfonylurea in Type 2 Diabetes.

✍ Scribed by Schmitz, O.; Russell-Jones, D.; Vaag, A.; Sethi, B.K.; lalic, N.; Antic, S.; Zdravkovic, M.; Ravn, G.M.; Simo, R.

Book ID: 122492685
Publisher: Canadian Diabetes Association
Year: 2008
Tongue: English
Weight: 702 KB
Volume: 32
Category: Article
ISSN: 1499-2671
DOI: 10.1016/S1499-2671(08)24116-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Significantly Better Glycemic Control an

Significantly Better Glycemic Control and Weight Reduction with Liraglutide, a Once-Daily Human GLP- 1 Analog, Compared With Glimepiride: All as Monotherapy In Type 2 Diabetes.

✍ Garber, A.; Henry, R.; Ratner, R.; Garcia-Hernandez, P.; Rodriquez Pattzi, H.M.; 📂 Article 📅 2008 🏛 Canadian Diabetes Association 🌐 English ⚖ 701 KB

Liraglutide, a Once-daily Human GLP-1 An

Liraglutide, a Once-daily Human GLP-1 Analog, In Type 2 Diabetes Provides Similar Glycemic Control with Reduced Body Weight Compared with Glimepiride when Added to Metformin.

✍ Frid, A.; Nauck, M.A.; Hermansen, K.; Shah, N.S.; Tankova, T.; Mitha, I.H.; Duri 📂 Article 📅 2008 🏛 Canadian Diabetes Association 🌐 English ⚖ 681 KB

Liraglutide, a Once-daily Human GLP-1 An

Liraglutide, a Once-daily Human GLP-1 Analog, In Type 2 Diabetes Provides Similar Glycem1c Control with Reduced Body Weight Compared with Glimepiride when Added to Metformin.

✍ Frid, A.; Nauck, M.A.; Hermansen, K.; Shah, N.S.; Tankova, T.; Mitha, I.H.; Duri 📂 Article 📅 2008 🏛 Canadian Diabetes Association 🌐 English ⚖ 681 KB

Improved glycaemic control with minimal

Improved glycaemic control with minimal hypoglycaemia and no weight change with the once-daily human glucagon-like peptide-1 analogue liraglutide as add-on to sulphonylurea in Japanese patients with type 2 diabetes

✍ K. Kaku; M. F. Rasmussen; P. Clauson; Y. Seino 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

Weight loss with liraglutide, a once-dai

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

✍ J. Jendle; M. A. Nauck; D. R. Matthews; A. Frid; K. Hermansen; M. Düring; M. Zdr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Liraglutide, a once-daily human GLP-1 an

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

✍ Marre, M. (author);Shaw, J. (author);Brändle, M. (author);Bebakar, W. M.W. (auth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB